Stephen Hatfield

Stephen Hatfield

Company: Northeastern University

Job title: Assistant Professor


Therapeutic Targeting of Hypoxia-A2-Adenosinergic Signaling to Improve the Outcomes Oxygen-Ventilated COVID-19 Patients 4:45 pm

• Harnessing the A2A adenosine receptor axis to prevent oxygen-mediated exacerbation of inflammation in COVID-19 patients with acute respiratory distress syndrome • Understanding the tissue-protecting role of hypoxia and adenosine in infectious diseases and COVID-19 and strategies to improve protocols of supplemental oxygenationRead more

day: Day Two

Anti-hypoxia Treatments to Reprogram The Tumor Microenvironment & Improve Cancer Immunotherapies 10:10 am

• Addressing the acute need in strategies to target the most upstream stage of the hypoxia- A2-adenosinergic pathway of immunosuppression in the tumor microenvironment (TME) • Emphasizing reprogramming the TME by eliminating tumor hypoxia to improve outcomes of current cancer immunotherapiesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.